PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Caraway Oil→

Caraway Oil PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
8000-42-8
Molecular formula
Not available
Molecular weight
Not available
Drug class
Botanical essential oil (Carum carvi)traditional carminative and gastrointestinal herbal preparation
Mechanism of action
Caraway essential oil contains volatile constituents including carvone and limonene. It is traditionally used for carminative and antispasmodic effects in the gastrointestinal tract; the precise pharmacological contribution of individual constituents is not fully established.
Indications / reported uses
  • Traditional symptomatic relief of mild gastrointestinal complaints such as bloating and flatulence in authorised herbal medicinal products; use is formulation- and jurisdiction-specific

Sources: EMA herbal monograph and assessment reports — Carum carvi · PubMed — Caraway oil gastrointestinal pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Caraway Oil PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Caraway Oil Permitted Daily Exposure (PDE) report (the Caraway Oil PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Caraway Oil Occupational Exposure Limit (OEL) report (the Caraway Oil OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.